← Back to headlines
Eli Lilly Expands AI Drug Discovery Partnership with Insilico Medicine
Eli Lilly is deepening its commitment to artificial intelligence in drug discovery by expanding its existing partnership with Insilico Medicine.
30 Mar, 13:36 — 30 Mar, 13:36
Sources
Showing 1 of 1 sources

